Autres langues Mentice AB

Actions

Marché Fermé - Nasdaq Stockholm Autres places de cotation 13:46:04 26/04/2024			Varia. 5j.	Varia. 1 janv.
36,1 ^SEK	-0,82 %		+0,28 %	-24,32 %

02/04	Mentice reçoit une commande de 795 000 USD pour des services de développement de la part d'un leader mondial des technologies médicales	CI
21/03	Transcript : Mentice AB - Analyst/Investor Day

Mentice to present the company's Q1 Interim Report	26/04
Correction: Mentice publishes Annual Report 2023	24/04
Annual shareholders meeting in Mentice AB	24/04
Mentice publishes Annual Report 2023	24/04
Annual shareholders’ meeting in Mentice AB	23/04
Mentice receives an order of USD 795,000 for development services from a world-leading MedTech company	02/04
Mentice Receives an Order of USD 795,000 for Development Services from A World-Leading Medtech Company	02/04
BioStock: Mentice updates strategy and goals at Capital Markets Day	26/03
Mentice presents financial targets and updated strategic direction to take advantage of current market opportunities	21/03
Invitation to Mentice's Capital Markets Day on 21 March 2024	26/02
Invitation to Mentice’s Capital Markets Day on 21 March 2024	23/02
Mentice and UNICEN Announce Collaboration to Advance Cardiovascular Healthcare Technologies	21/02
Mentice AB and Unicen Announce Collaboration to Advance Cardiovascular Healthcare Technologies	21/02
Mentice Q4 2023 - Ability is nothing without opportunity	16/02
Mentice publishes the company’s year-end report for the period January–December 2023	15/02
Mentice AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	15/02
Mentice to present Year-end Report Q4	08/02
Mentice’s Ankyras Software Gains US FDA Clearance; Shares Up	04/01
Mentice receives FDA 510(k) Clearance for ANKYRAS™	04/01
Mentice Receives FDA 510(K) Clearance for Ankyras	04/01

Aucun résultat pour cette recherche